PARIS, December 21, 2015 /PRNewswire/ --
Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, announced today its schedule for the publication of financial information for 2016.
Event Date *
2015 Full-Year Sales January 26, 2016
2015 Full-Year Results March 24, 2016
2016 First-Quarter Sales April 27, 2016
2016 First-Half Sales July 27, 2016
2016 First-Half Results September 21, 2016
2016 Third-Quarter Sales November 2, 2016
* Subject to modification. Press releases are published after market closes.
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company focused on protecting patients' lives while enabling physicians and surgeons to make better decisions thanks to direct visualization at the cellular level. The Company's flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico. For more information on Mauna Kea Technologies, visit www.maunakeatech.com
Mauna Kea Technologies
Investors relations US
Sebastien Cadet
Global Marketing Director and OEM Leader
sebastienc@maunakeatech.com
NewCap.
Investor Relations Europe
Florent Alba
Tel: +33 (0) 1 44 71 94 94
maunakea@newcap.fr
This is a disclosure announcement from PR Newswire.